Dubai, May 24, 2022 (WAM) – The first Precision Medicine Expo and Summit in the Middle East, in conjunction with the EMERGE Gulf Health Innovation Forum, opened today for two days at the Conrad Hotel in Dubai. Thought leaders and medical pioneers from Asia, the Middle East, Europe and the United States have teamed up to unveil new opportunities for precision medicine (PM) based on digital technology.
The event was sponsored by Sheikh Nahyan bin Mubarak Al Nahyan, Minister for Tolerance and Coexistence and President of the UAE Genetic Diseases Association.
More than 100 international biotech and health tech entrepreneurs will travel to Dubai to attract investment for their game-changing start-ups that they believe will reduce health insurance costs, reduce hospital admissions, reduce patient burden and improve quality of life.
Meanwhile, EMERGE GHI brings together healthcare innovators and investors through more than 300 hours of networking opportunities and helps dynamic entrepreneurs gain deeper concentration of capital and knowledge from part of global hitmakers, including representatives from some of the region’s biggest names. Plug and Play, Hikma Ventures and Kuwait Life Sciences Company.
Dealroom.co, a global startup and venture capital intelligence platform, identifies health technology as the strongest Middle East and North Africa (MENA) vertical growth in combined enterprise pricing since 2016, making the Dubai event the right forum at the right time.
Event director David Stradling said, “The value of the health technology startup ecosystem in the MENA region is over US $ 1.5 billion, which has increased 22-fold since 2016.” “Healthtech startups in the region have been starting since 2016, with US $ 200 million in venture capital funding. Annual investment in digital health infrastructure at GCC alone is expected to increase from US $ 0.5 billion to US $ 1.2 billion over the next two years, up from 3% to 4% in the previous year.” Increased from 10% to 20% compared to%.
“Over the next ten years, virtual care, remote patient monitoring and artificial intelligence will account for 30% of hospital investments in this area. Most of this activity will be driven by private players. An important opportunity for startups Solutions need to be integrated.
“As the pace of epidemic innovation accelerates, there has never been a greater sense of urgency and need for a new platform to advance healthcare. Domestic investors and foreigners are working to advance health technology in the MENA region, raising US $ 930 million since 2020. Dedicated funds, and this is just the beginning. EMERGE GHI will lead the way in meeting the future needs of healthcare. “
Thanks to dynamic innovators from around the world who have traveled to Dubai, EMERGE GHI will provide participants with an insight into the future of healthcare. US company BioSapien Inc. Looking for partners for its 3D-printed biodegradable implantable mesh, aimed at delivering FDA-approved drugs directly to cancer cells, with the aim of reducing harmful side effects and costs. CEO and founder Khatija Ali believes that the UAE offers partnership opportunities for biotech breakthroughs and hopes that its Medichip will resonate with investors.
“Current cancer treatment methods do not match the capabilities of today’s technology. We need to rethink the way we provide cancer care and potentially other drugs. We are starting with topical chemotherapy to avoid dose-limited toxicity. There is no small achievement, and we We want to find thinkers who can see the big picture. Finally, we are looking for funding commitments for the successful launch of the A-Series that will help bring our technology closer to patients, “said Ali.
Co-located with EMERGE GHI PrecisionMed Expo and Summit – the first and only exhibition and summit in the Middle East dedicated to the field of Precision Medicine (PM) based on digital technology. The event will bring together more than 70 international experts, thought leaders and medical pioneers from Asia, the Middle East, Europe and the United States to provide insights into new approaches to “one-size-fits-all healthcare.” All fit “method for a targeted and personalized approach.
Translator: Jihane Fawzi.